The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 413K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Charbonnier, A.-S.
Right arrow Articles by Maurer, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Charbonnier, A.-S.
Right arrow Articles by Maurer, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1999/12/1755/ $5.00
The Journal of Experimental Medicine, Volume 190, Number 12, December 20, 1999 1755-1768


Original Article

Macrophage Inflammatory Protein 3{alpha} Is Involved in the Constitutive Trafficking of Epidermal Langerhans Cells

Anne-Sophie Charbonniera, Norbert Kohrgrubera, Ernst Kriehubera, Georg Stingla, Antal Rotb, and Dieter Maurera

a Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, University of Vienna Medical School, A-1090 Vienna, Austria
b Novartis Forschungsinstitut, A-1235 Vienna, Austria
Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology, University of Vienna Medical School, Waehringer Guertel 18-20, A-1090 Vienna, Austria. Telephone: 43-1-40-400-7769;43-1-403-1900

dieter.maurer{at}akh-wien.ac.at

Certain types of dendritic cells (DCs) appear in inflammatory lesions of various etiologies, whereas other DCs, e.g., Langerhans cells (LCs), populate peripheral organs constitutively. Until now, the molecular mechanism behind such differential behavior has not been elucidated. Here, we show that CD1a+ LC precursors respond selectively and specifically to the CC chemokine macrophage inflammatory protein (MIP)-3{alpha}. In contrast, CD14+ precursors of DC and monocytes are not attracted by MIP-3{alpha}. LCs lose the migratory responsiveness to MIP-3{alpha} during their maturation, and non-LC DCs do not acquire MIP-3{alpha} sensitivity. The notion that MIP-3{alpha} may be responsible for selective LC recruitment into the epidermis is further supported by the following observations: (a) MIP-3{alpha} is expressed by keratinocytes and venular endothelial cells in clinically normal appearing human skin; (b) LCs express CC chemokine receptor (CCR)6, the sole MIP-3{alpha} receptor both in situ and in vitro; and (c) non-LC DCs that are not found in normal epidermis lack CCR6. The mature forms of LCs and non-LC DCs display comparable sensitivity for MIP-3β, a CCR7 ligand, suggesting that DC subtype–specific chemokine responses are restricted to the committed precursor stage. Although LC precursors express primarily CCR6, non-LC DC precursors display a broad chemokine receptor repertoire. These findings reflect a scenario where the differential expression of chemokine receptors by two different subpopulations of DCs determines their functional behavior. One type, the LC, responds to MIP-3{alpha} and enters skin to screen the epidermis constitutively, whereas the other type, the "inflammatory" DC, migrates in response to a wide array of different chemokines and is involved in the amplification and modulation of the inflammatory tissue response.

Key Words: Langerhans cell • dendritic cell • chemokine • migration • epidermis


Abbreviations used in this paper: CB, cord blood; CCR, CC chemokine receptor; CXCR, CXC chemokine receptor; DC, dendritic cell; DMEC, dermal microvascular EC; EC, endothelial cell; E-cad, E-cadherin; HPC, hematopoietic precursor cell; HUVEC, human umbilical vein EC; LC, Langerhans cell; MCP, monocyte chemotactic protein; mdDC, monocyte-derived DC; MIP, macrophage inflammatory protein; MNC, mononuclear cell; PB, peripheral blood; PerCP, peridinin chlorophyll protein; PFA, paraformaldehyde; RANTES, regulated upon activation, normal T cell expressed and secreted; RPE, R-phycoerythrin; RT, reverse transcription; SA-Cy5, Cy5 RPE–conjugated streptavidin; SDF, stromal cell–derived factor; SLC, secondary lymphoid tissue chemokine.

© 1999 The Rockefeller University Press


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS